Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2

Gene Therapy

Volumn 3, Issue 2, 1996, Pages 117-127

  Kaplan, J M ^a   St George, J A ^a   Pennington, S E ^a   Keyes, L D ^a   Johnson, R P ^b   Wadsworth, S C ^a   Smith, A E ^a  

^a GENZYME CORPORATION   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus; Cytotoxic T cell; Gene therapy; Neutralization; Proliferation

Indexed keywords

CD8 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; SECRETORY IMMUNOGLOBULIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL KILLING; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; EXPRESSION VECTOR; FIBROBLAST; GENE THERAPY; HUMORAL IMMUNITY; LUNG; LUNG LAVAGE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SERUM; SPLEEN; T LYMPHOCYTE;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD; BRONCHOALVEOLAR LAVAGE FLUID; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE THERAPY; GENETIC VECTORS; IMMUNOGLOBULIN A; LYMPH NODES; LYMPHOCYTE ACTIVATION; MACACA MULATTA; NEUTRALIZATION TESTS; SPLEEN; T-LYMPHOCYTES;

ADENOVIRIDAE; ANIMALIA; MACACA MULATTA; PRIMATES;

EID: 0029968303     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kantoff PW et al. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 1986; 83: 6563-6567.
2. Stratford-Perricaudet L, Perricaudet M. Gene transfer into animals. The promise of adenovirus. In: Cohen-Haguenauer O, Boiron M (eds). Human Gene Transfer. INSERM/John Libbey Eurotext: Paris, 1991, pp 51-62.
3. Evans MJ, Shami SG. Lung cell kinetics. In: Lenfant C, Massaro D (eds). Lung Cell Biology. Marcel Dekker: New York, 1989, pp 1-36.
4. Zabner J et al. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet 1994; 6: 75-83.
5. Engelhardt JF et al. Adenovirus-mediated transfer of the CFTR gene to the lung of nonhuman primates: biological efficacy study. Hum Gene Ther 1993; 4: 759-769.
6. Crystal RG et al. Administration of an adenovirus containing the human CFlK cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8: 42-51.
7. Brody SL et al. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gem Ther 1994; 5: 821-836.
8. Zabner J et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75: 207-216.
9. Zabner J, Couture LA, Smith AE, Welsh MJ. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro. Hum Gene Ther 1994; 5: 585-593.
10. Rosenfeld MA et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68:143-155.
11. Rich DP et al. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther 11993; 4: 461-476.
12. Mittereder N et al Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther 1994; 5: 719-731.
13. Grubb BR et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 1994; 371: 802-806.
14. Simon RH et al. Adenovirus-mediated transfer of the CFTR gene to lung of non-human primates: toxicity study. Hum Gene Ther 1993; 4: 771-780.
15. Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 1994; 7: 362-369.
16. Engelhardt JF, Litzky L, Wilson JM. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther 1994; 5: 1217-1229.
17. Yei S et al. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum Gene Ther 1994; 5: 731-744.
18. Bout A et al. Lung gene therapy: in vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium. Hum Gene Ther 1994; 5: 3-10.
19. Bout A et al. In vivo adenovirus-mediated transfer of human CFTR cDNA to Rhesus monkey airway epithelium: efficacy, toxicity and safety. Gene Therapy 1994; 1: 385-394.
20. St George JA et al. Biological response of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Therapy 1996; 3. 103-116.
21. Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
22. Mastrangeli A et al. Efficient in vivo adenovirus-mediated gene transfer to the airway epithelium of animals immunized with different adenovirus serotypes. Eight Annual North American Cystic Fibrosis Conference 1994; Orlando, FL; 20-23 October; Abstract no. 13A.
23. Yei S et al. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Therapy 1994; 1: 192-200.
24. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987; 7: 265-276.
25. Willimzik H-F, Kalter SS, Lester TL, Wigand R. Immunological relationship among adenoviruses of humans, simians, and non-primates as determined by the neutralization test. Intervirology 1981; 15: 28-36.
26. Rawle FC, Tollefson AE, Wold WSM, Gooding LR. Mouse antiadenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J Immunol 1989; 143; 2031-2037.
27. Beier DC et al. Association of human Class I MHC alleles with the adenovirus E3/19K protein. J Immunol 1994; 152: 3862-3872.
28. Berke G. The functions and mechanisms of action of cytolytic lymphocytes. In: Paul WE (ed). Fundamental Immunology. Raven Press: New York, 1993, pp 965-1014.
29. Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985; 6: 131-134 .
30. Stein-Streilein J, Toews GB. Leukocytes in the lung. In: Lenfant C, Massaro D (eds). Lung Cell Biology. Marcel Dekker: New York, 1989, pp 441-463.
31. Cook JL, May DL, Lewis AM Jr, Walker TA. Adenovirus ElA gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells. J Virol 1987; 61: 3510-3520.
32. Routes JM, Cook JL. Adenovirus persistence in man. Defective ElA gene product targeting of infected cells for elimination by natural killer cells. J Immunol 1989; 142: 4022-4026.
33. Routes JM. IFN increases Class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing. J Immunol 1992; 149: 2372-2377.
34. Armentano D et al. A second generation adenovirus gene transfer vector containing an E4 deletion. Hum Gene Ther 1995; 6: 1343-1353.
35. Rich DP et al. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther 1993; 4: 461-476.
36. O'Riordan CR et al. Purification and characterization of recombinant cystic fibrosis transmembrane conductance regulator from Chinese hamster ovary and insect cells. J Biol Chem 1995; 270: 17033-17043.